Molecular pathology of pancreatic cancer: from bench-to-bedside translation.

Abstract:

:Pancreatic ductal adenocarcinoma (referred here as pancreatic cancer) is a lethal disease with the worst prognosis among all solid tumors. Surgical resection represents the only hope for cure but it is possible only in patients that present with local disease (about 20% of cases). Whether dismal prognosis of pancreatic cancer is a result of late diagnosis or early dissemination to distant organ is still a debate. Moreover, this disease shows an intrinsic chemotherapeutic resistance that has been mainly ascribed to the presence of a dense stromal reaction that significantly impairs drugs delivery. Clinical management of pancreatic cancer patients relies on few molecular markers (e.g., the diagnostic marker CA19-9) that, however, present several limitations to their use. The clinical usefulness of somatic alterations in well-characterized genes (such as KRAS and TP53), whose detection is technically feasible in different biological samples, has been extensively investigated leading to inconsistent results. Furthermore, none of the candidate molecular markers identified in recent years has shown an appropriate clinical performance and therefore none is routinely used. This depicts a scenario where the identification of novel and effective clinical biomarkers is mandatory. Very recent genome-wide comprehensive studies have shed light on the high degree of genetic complexity and heterogeneity of the pancreatic cancers. Although far from being introduced into the clinical settings, results from those studies are expected to change definitively the perspective through which we look at the clinical management of pancreatic cancer patients towards a personalized cancer medicine.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Corbo V,Tortora G,Scarpa A

doi

10.2174/138945012800564103

subject

Has Abstract

pub_date

2012-06-01 00:00:00

pages

744-52

issue

6

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-20120328-003

journal_volume

13

pub_type

杂志文章,评审
  • Update on statins: hope for osteoporotic fracture healing treatment.

    abstract::Fracture healing is a process of recovering injured bone tissue forms and functions. Osteoporosis can delay the healing process, which contributes to personal suffering and loss of activities. Osteoporosis patients tend to lose bone mass at the metaphyseal region which require treatment to increase bone mass. Postmeno...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990195

    authors: Ibrahim N',Mohamed N,Shuid AN

    更新日期:2013-12-01 00:00:00

  • ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors.

    abstract:BACKGROUND:Pediatric tumors remain the highest cause of death in developed countries. Research on novel therapeutic strategies with lesser side effects is of utmost importance. In this scenario, the role of Renin-Angiotensin System (RAS) axes, the classical one formed by angiotensinconverting enzyme (ACE), Angiotensin ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200210124217

    authors: de Paula Gonzaga ALAC,Palmeira VA,Ribeiro TFS,Costa LB,de Sá Rodrigues KE,Simões-E-Silva AC

    更新日期:2020-01-01 00:00:00

  • Inflammation, serotonin and major depression.

    abstract::The understanding of the neurobiological processes leading to major depressive disorder (MDD) is an active field of research in the scientific community. For years, the alteration of monoamine neurotransmission, in particular serotonin (5-HT), has been considered the most significant pathophysiological mechanism of th...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990154

    authors: Catena-Dell'Osso M,Rotella F,Dell'Osso A,Fagiolini A,Marazziti D

    更新日期:2013-05-01 00:00:00

  • Affinity-based methods in drug-target discovery.

    abstract::Target discovery using the molecular approach, as opposed to the more traditional systems approach requires the study of the cellular or biological process underlying a condition or disease. The approaches that are employed by the "bench" scientist may be genetic, genomic or proteomic and each has its rightful place i...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450115666141120110323

    authors: Rylova G,Ozdian T,Varanasi L,Soural M,Hlavac J,Holub D,Dzubak P,Hajduch M

    更新日期:2015-01-01 00:00:00

  • Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer.

    abstract::While breast cancer (BC) is commonest malignancy among female with highest death rate, male breast cancer (MBC) is very rare but exhibits highest cancer specific death in men and the incidences of MBCs are rising rapidly. Due to rarity of the disease, no detail information about biomarkers and drug targets available a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787122842

    authors: Barh D

    更新日期:2009-01-01 00:00:00

  • Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment.

    abstract::Nowadays, natural compounds of plant origin with anticancer effects have gained more attention because of their clinical safety and broad efficacy profiles. Autophagy is a multistep lysosomal degradation pathway that may have a unique potential for clinical benefit in the setting of cancer treatment. To retrieve artic...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200504072635

    authors: Forouzanfar F,Mousavi SH

    更新日期:2020-01-01 00:00:00

  • Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.

    abstract::Long term treatment with antiepileptic drugs (AEDs) is the standard therapeutic approach to eradicate seizures. However, a small but significant number of patients fail AED treatment. Intrinsic drug resistance may depend on two main and not necessarily mutually exclusive mechanisms: 1) Loss of pharmacological target (...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033491109

    authors: Marroni M,Marchi N,Cucullo L,Abbott NJ,Signorelli K,Janigro D

    更新日期:2003-05-01 00:00:00

  • Tachykinins: role in human gastrointestinal tract physiology and pathology.

    abstract::Tachykinins (TKs) and their receptors (NK1, NK2 and NK3), which are diffusely expressed in the human gastrointestinal tract, represent an endogenous modulator system regulating enteric secretomotor functions, inflammatory and immune responses, and visceral hypersensitivity, mainly during pathological gut diseases. Pat...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778019354

    authors: Improta G,Broccardo M

    更新日期:2006-08-01 00:00:00

  • Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

    abstract::Alzheimer's, a degenerative cause of the brain cells, is called as a progressive neurodegenerative disease and appears to have a heterogeneous etiology with main emphasis on amyloid-cascade and hyperphosphorylated tau-cascade hypotheses, that are directly linked with macromolecules called enzymes such as β- & γ-secret...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450119666180820104723

    authors: Alam J,Sharma L

    更新日期:2019-01-01 00:00:00

  • Mitochondrial drug targets in apicomplexan parasites.

    abstract::In evolutionary terms, mitochondria in apicomplexan parasites appear to be "relicts-in-the-making": they possess the smallest mitochondrial genomes known, encoding only three proteins, and in one genus, Cryptosporidium, the genome is eliminated altogether. Several features of mitochondrial physiology provide validated...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779315632

    authors: Mather MW,Henry KW,Vaidya AB

    更新日期:2007-01-01 00:00:00

  • Aging of Brain Related with Mitochondrial Dysfunctions.

    abstract::Advancing age presents a major challenge for the elderly population in terms of quality of life. The risk of cognitive impairment, motor in-coordination, and behavioral inconsistency due to neuronal damage is relatively higher in aging individuals of society. The brain, through its structural and functional integrity,...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121999201209202247

    authors: Dhote V,Samundre P,Ganeshpurkar A,Upaganlawar A

    更新日期:2020-12-09 00:00:00

  • Thrombomodulin links coagulation to inflammation and immunity.

    abstract::Thrombomodulin (TM) is a type 1 membrane bound glycoprotein that has a C-type lectin domain at its Nterminus, 6 copies of the epidermal growth factor-like (EGF) motif and serine/threonine rich domain carrying a glycosoaminoglycan external to the membrane. TM binds thrombin changing thrombin's substrate specificity fro...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012799424606

    authors: Morser J

    更新日期:2012-03-01 00:00:00

  • Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.

    abstract::Classical antidepressant drugs such as Selective Serotonin Reuptake Inhibitors (SSRIs) display several disadvantages, e.g., the onset of action (2 to 3 weeks) to start clinical benefits is too long, and a significant proportion of patients do not respond to this monotherapy. Several strategies have been proposed to ov...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006775515428

    authors: Guiard BP,Lanfumey L,Gardier AM

    更新日期:2006-02-01 00:00:00

  • Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

    abstract::Terpenoids represent a large and diverse class of naturally occurring compounds found in a variety of fruits, vegetables and medicinal plants. Structurally some of the terpenoids are similar to human hormones. A diet rich in terpenoids is inversely related with the risk of chronic diseases including cancers. Breast an...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010791170842

    authors: Yang H,Dou QP

    更新日期:2010-06-01 00:00:00

  • The Epitome of Novel Techniques and Targeting Approaches in Drug Delivery for Treating Lymphatic Filariasis.

    abstract:BACKGROUND:Lymphatic filariasis is a pervasive and life-threatening disease for human beings. Currently, 893 million people in 49 countries worldwide affected by lymphatic filariasis as per WHO statistics. The concealed aspects of lymphatic diseases such as delayed disease detection, inappropriate disease imaging, the ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200630111250

    authors: Shrivastava S,Gupta A,Kaur CD

    更新日期:2020-01-01 00:00:00

  • Catalytic DNA: a novel tool for gene suppression.

    abstract::RNA, as an intermediate in the production of every gene encoded protein and the genetic material of many pathogenic viruses, presents an attractive target for both biological and therapeutic manipulation. Despite its extensive involvement in living systems, its chemical diversity based on four units is relatively low ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450023347722

    authors: Cairns MJ,Saravolac EG,Sun LQ

    更新日期:2002-06-01 00:00:00

  • Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?

    abstract:BACKGROUND:Galanin (GAL) constitutes a family of neuropeptides composed of four peptides: (i) galanin (GAL), (ii) galanin-message associated peptide (GAMP), (iii) galanin-like peptide (GALP), and (iv) alarin. GAL contains 29/30 amino acids, and its biological action occurs through the interactions with its various rece...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200225112055

    authors: Oliveira Volpe CM,Vaz T,Rocha-Silva F,Villar-Delfino PH,Nogueira-Machado JA

    更新日期:2020-01-01 00:00:00

  • Doxorubicin Action on Mitochondria: Relevance to Osteosarcoma Therapy?

    abstract:BACKGROUND:The mitochondria may very well determine the final commitment of the cell to death, particularly in times of energy stress. Cancer chemotherapeutics such as the anthracycline doxorubicin perturb mitochondrial structure and function in tumour cells, as evidenced in osteosarcoma, for which doxorubicin is used ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150416115852

    authors: Armstrong J,Dass CR

    更新日期:2018-01-01 00:00:00

  • Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer.

    abstract::Colorectal cancer (CRC) is one of the most common cancers worldwide. In developed countries, its mortality remains high, yet the prevalence has established owing to effective screening programs; however due to the westernization of lifestyle, the incidences in many other countries have increased. Although the treatmen...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450120666191112141901

    authors: Bartoszek A,Fichna J,Tarasiuk A,Binienda A,Fabisiak A,Krajewska JB,Mosińska P,Niewinna K,Salaga M

    更新日期:2020-01-01 00:00:00

  • Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site.

    abstract::Nature provides science and society with a virtually unlimited supply of structurally diverse and biologically active molecules; the natural products. While some are directly useful in commercial applications, others are valuable for studying and understanding biological phenomena at the molecular level. An example is...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011798109509

    authors: Nilsson J,Sterner O

    更新日期:2011-10-01 00:00:00

  • Nanotheranostics in evidence based personalized medicine.

    abstract::Efficient drug delivery systems are exceedingly important for novel drug discovery. The evidence-based personalized medicine (EBPM) promises to deliver the right drug at the right time to a right patient as it covers clinicallysignificant genetic predisposition and chronopharmacological aspects of nanotheranostics. Re...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:

    authors: Sharma S

    更新日期:2014-01-01 00:00:00

  • Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.

    abstract::Overexpression of the human epidermal growth factor receptor 2 (HER2) is identified in approximately 25- 30% of breast cancers and indicates a poor prognosis. Trastuzumab, the anti-HER2 monoclonal antibody (mAb), has shown significant clinical effects selectively in HER2-overexpressing metastatic breast cancer (MBC) w...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990161

    authors: Huang Y,Fu P,Fan W

    更新日期:2013-07-01 00:00:00

  • Targeting plasminogen activator inhibitor-1: role in cell signaling and the biology of domain-specific knock-in mice.

    abstract::It is well documented that elevated levels of PAI-1 in plasma can decrease the fibrinolytic activity in blood with an associated increased risk of thrombus formation. A diverse range of molecules including bacterial lipopolysaccharide (LPS), the inflammatory mediators tumor necrosis factor alpha (TNFalpha) and interle...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007781662382

    authors: Balsara RD,Xu Z,Ploplis VA

    更新日期:2007-09-01 00:00:00

  • The complex biology of FOXO.

    abstract::FOXO transcription factors control proliferation, apoptosis, differentiation and metabolic processes. Loss of FOXO function has been identified in several human cancers, and results in increased cellular survival and a predisposition to neoplasia, especially in epithelial cancer. FOXO factors are therefore bona fide t...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011796150307

    authors: Monsalve M,Olmos Y

    更新日期:2011-08-01 00:00:00

  • Notch-associated microRNAs in cancer.

    abstract::The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Thus, alterations of the Notch signaling can lead to a variety of disorders including human malignancies. Of considerable interest, recent evidence indicates that there is a significant cross-talk betw...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990188

    authors: Mo YY,Tang H,Miele L

    更新日期:2013-09-01 00:00:00

  • Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review.

    abstract::Due to potential health benefits and the general assumption that natural products are safe, there is an increasing trend in the general population - including pregnant women - to supplement their diet with flavonoid-based food supplements. In addition, preclinical studies aim to prevent developmental adverse effects i...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150804110049

    authors: Barenys M,Masjosthusmann S,Fritsche E

    更新日期:2017-01-01 00:00:00

  • Patient-controlled analgesia.

    abstract::Using a portable infusion pump, intravenous opioid patient-controlled analgesia (PCA) permits a patient to self-deliver a small bolus of opioid to achieve prompt relief without over sedation. Use of PCA for pain management is increasing in hospitals, largely because it can provide equivalent or better analgesia than c...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945005774574524

    authors: Mann C,Ouro-Bang'na F,Eledjam JJ

    更新日期:2005-11-01 00:00:00

  • Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours.

    abstract::Methionine aminopeptidases (MetAP) are intracellular metalloproteins responsible for the removal of the initiator NH(2)-terminal methionine from newly synthesized proteins, thereby facilitating their intracellular translocation from the ribosome. Two types of MetAP enzymes, MetAP-1 (type-I) and MetAP-2 (type-II), whic...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111009011439

    authors: Mauriz JL,Martín-Renedo J,García-Palomo A,Tuñón MJ,González-Gallego J

    更新日期:2010-11-01 00:00:00

  • Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias.

    abstract::The last decade has witnessed the introduction of a large number of novel, molecularly targeted agents into the therapeutic armamentarium against diverse forms of cancer, including leukemia. Such agents include signal transduction, cell cycle, histone deacetylase, Hsp90, proteasome, and Bcl-2 family member inhibitors,...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007780830764

    authors: Grant S,Dent P

    更新日期:2007-06-01 00:00:00

  • Mucosal healing and anti TNFs in IBD.

    abstract::Mucosal healing has been incorporated in the assessment of treatment efficacy in ulcerative colitis, but in Crohn's disease this concept has only emerged after biological therapies have been evaluated in clinical trials. Systemic steroids don't induce mucosal healing in Crohn's disease, but purine analogues and anti T...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945010790309902

    authors: van Assche G,Vermeire S,Rutgeerts P

    更新日期:2010-02-01 00:00:00